Resilience (@IncResilience) / X

Pinned

Feb 5, 2024

NEWS: We have entered into a joint venture with Taiwan Bio-Manufacturing Corporation. The collaboration aims to address the growing need for technology-enabled, end-to-end solutions for complex medicines. Learn more: hubs.ly/Q02jPz2-0

We are honored to receive the James A. Wuenker Growth Award from @GrowCincyUSA as a result of the expansion we announced in December 2023 to our West Chester, Ohio biomanufacturing site. Learn more: hubs.ly/Q02qWNwz0

This #RareDiseaseDay, we are honored to partner with @BridgeBioPharma, as together we remain dedicated to accelerating the development of innovative therapies for families living with Canavan disease and congenital adrenal hyperplasia. Learn more:hubs.ly/Q02m7dxY0

Resilience

@IncResilience

Feb 20, 2024

News! We’re expanding our drug product manufacturing capabilities with a $225M investment in Cincinnati facility, plus expansion in RTP. Read more: hubs.ly/Q02lD1ZS0 #Biomanufacturing #DrugDevelopment

Resilience

@IncResilience

Feb 4, 2024

Today is #WorldCancerDay. As a technology-focused biomanufacturing company, we are proud to support multiple partners within the oncology space. We remain committed to working alongside our partners to provide lifesaving treatments for cancer patients.